Literature DB >> 27203106

Lessons from a Recovering Academic.

Michael D Ehlers1.   

Abstract

The conversion of basic biology into new therapeutics requires scientific activities in both academia and industry. Successful drug discovery projects span disciplines, sectors, and institutions and tightly couple laboratory and clinical experiments. Here, Ehlers describes conceptions and misconceptions about how science is conducted in industry versus academia.
Copyright © 2016 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2016        PMID: 27203106     DOI: 10.1016/j.cell.2016.05.005

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  3 in total

1.  Creativity in large pharmaceutical research organizations: unleash the hungry drug hunter.

Authors:  Guy Griebel
Journal:  Br J Pharmacol       Date:  2017-04-03       Impact factor: 8.739

2.  Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.

Authors:  Magdalena Zwierzyna; Mark Davies; Aroon D Hingorani; Jackie Hunter
Journal:  BMJ       Date:  2018-06-06

3.  Strong Inference in Mathematical Modeling: A Method for Robust Science in the Twenty-First Century.

Authors:  Vitaly V Ganusov
Journal:  Front Microbiol       Date:  2016-07-22       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.